Vanguard Group Inc Abiomed Inc Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$242.49 - $301.46 $69.8 Million - $86.8 Million	287,915 Added 5.78%	5,269,340 $1.29 Billion
Q2 2022 Aug 12, 2022	BUY	$224.73 - $338.64 $15.8 Million - $23.7 Million	70,088 Added 1.43%	4,981,425 $1.23 Billion
Q1 2022 May 13, 2022	BUY	$277.25 - $366.29 $19 Million - $25 Million	68,353 Added 1.41%	4,911,337 $1.63 Billion
Q4 2021 Feb 14, 2022	BUY	$300.63 - $371.35 $11 Million - $13.5 Million	36,479 Added 0.76%	4,842,984 $1.74 Billion
Q3 2021 Nov 12, 2021	SELL	$310.19 - $376.2 $22.8 Million - $27.7 Million	-73,514 Reduced 1.51%	4,806,505 $1.56 Billion
Q2 2021 Aug 13, 2021	BUY	$262.71 - $351.17 $1.28 Billion - $1.71 Billion	4,880,019 New	4,880,019 $1.52 Billion

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.